Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows

v3.7.0.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2017
Mar. 31, 2016
Statement of Cash Flows [Abstract]    
NET CASH (USED IN) PROVIDED BY OPERATING ACTIVITIES $ (1,442) $ 337
INVESTING ACTIVITIES    
Purchase of medical equipment and property (1,015) (3,274)
Proceeds from sale of medical equipment and property 1,525 884
NET CASH PROVIDED BY (USED IN) INVESTING ACTIVITIES 510 (2,390)
FINANCING ACTIVITIES    
Principal payments on revolving credit facility, term loans and capital lease obligations (6,413) (15,369)
Cash proceeds from revolving credit facility 4,099 17,081
Debt issuance costs (25)  
Common stock repurchased to satisfy statutory withholding on employee stock based compensation plans (20) (33)
Cash proceeds from stock plans 87 125
NET CASH (USED IN) PROVIDED BY FINANCING ACTIVITIES (2,272) 1,804
Net change in cash and cash equivalents (3,204) (249)
Cash and cash equivalents, beginning of period 3,398 818
Cash and cash equivalents, end of period $ 194 $ 569